Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-hour FEV1 profile of tiotropium in asthma
NCT01696071Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of tiotropium in asthma, sponsored by Boehringer Ingelheim. Started Sep 2012; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01696071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696071.